CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.

Pharmaceutical

CStone Pharmaceuticals

Jason Yang

Lian Liu

Qingmei Shi

Na Wen

Chao Arthur Wu

Juan Zhang

Anny-Yue Yin

Michael Choi

Jun Cheng

Josh Zhou

The current leadership team at CStone Pharmaceuticals has a wide range of experience in the pharmaceutical industry, with team members having worked as consultants, business developers, financial analysts, and scientists at various companies. They also have a variety of educational backgrounds, including degrees in chemistry, biochemistry, and molecular genetics from Peking University, the University of Pennsylvania, and UT Southwestern Medical Center.

Leadership Team

CEO and Executive Team

Leadership Team

About

Team members

Other teams at CStone Pharmaceuticals

CEO and Executive Team